Home
/
Lucid Diagnostics Inc.
/
Financials
/
Quarterly
Lucid Diagnostics Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Lucid Diagnostics Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$1.21M
Nov 12, 2025
Q2
2025
Jun 30, 2025
$1.16M
Aug 12, 2025
Q1
2025
Mar 31, 2025
$828.0K
May 13, 2025
Q3
2025
Sep 30, 2024
$1.17M
Nov 12, 2025
Q2
2025
Jun 30, 2024
$976.0K
Aug 12, 2025
Q1
2025
Mar 31, 2024
$1.00M
May 13, 2025
Q3
2024
Sep 30, 2023
$783.0K
Nov 12, 2024
Q2
2024
Jun 30, 2023
$159.0K
Aug 12, 2024
Q1
2024
Mar 31, 2023
$446.0K
May 13, 2024
Q3
2023
Sep 30, 2022
$76.0K
Nov 13, 2023
Q2
2023
Jun 30, 2022
$189.0K
Aug 14, 2023
Q1
2023
Mar 31, 2022
$189.0K
May 15, 2023
Q3
2021
Sep 30, 2021
$200.0K
Nov 23, 2021
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$1.21M
Nov 12, 2025
Q2
2025
Jun 30, 2025
$1.16M
Aug 12, 2025
Q1
2025
Mar 31, 2025
$828.0K
May 13, 2025
Q3
2025
Sep 30, 2024
$1.17M
Nov 12, 2025
Q2
2025
Jun 30, 2024
$976.0K
Aug 12, 2025
Q1
2025
Mar 31, 2024
$1.00M
May 13, 2025
Q3
2024
Sep 30, 2023
$783.0K
Nov 12, 2024
Q2
2024
Jun 30, 2023
$159.0K
Aug 12, 2024
Q1
2024
Mar 31, 2023
$446.0K
May 13, 2024
Q3
2023
Sep 30, 2022
$76.0K
Nov 13, 2023
Q1
2023
Mar 31, 2022
$189.0K
May 15, 2023
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($10.40M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($4.44M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($26.91M)
May 13, 2025
Q3
2025
Sep 30, 2024
($12.37M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($11.01M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($10.61M)
May 13, 2025
Q3
2024
Sep 30, 2023
($14.21M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($11.38M)
Aug 12, 2024
Q1
2024
Mar 31, 2023
($16.25M)
May 13, 2024
Q3
2023
Sep 30, 2022
($14.35M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($14.62M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($12.27M)
May 15, 2023
Q3
2022
Sep 30, 2021
($6.96M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($6.16M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($3.65M)
May 16, 2022
Q3
2021
Sep 30, 2020
($2.02M)
Nov 23, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($11.76M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($11.38M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($12.49M)
May 13, 2025
Q3
2025
Sep 30, 2024
($11.69M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($11.19M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($10.79M)
May 13, 2025
Q3
2024
Sep 30, 2023
($11.13M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($11.58M)
Aug 12, 2024
Q1
2024
Mar 31, 2023
($14.32M)
May 13, 2024
Q3
2023
Sep 30, 2022
($14.38M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($14.63M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($12.27M)
May 15, 2023
Q3
2022
Sep 30, 2021
($6.51M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($6.02M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($3.65M)
May 16, 2022
Q3
2021
Sep 30, 2020
($2.02M)
Nov 23, 2021